Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €16.88 EUR
Change Today -0.045 / -0.27%
Volume 0.0
SLS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 2:08 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by JANUS CAPITAL GROUP INC (SLS) in the last 6 months

Announced 04/10/15
15.00M for Cosi Inc.
Private Placement

Cosi Inc. (NasdaqCM:COSI) announced that it has entered into a stock purchase agreement for a private placement of 7,160,766 unregistered common shares at $2.16 per share for gross proceeds of $15,467,255 on April 10, 2015. The transaction included participation from accredited existing investors, Goose Hill Capital Ltd., The Bigger Capital Fund, LP, new investors, Trishield Special Situations Master Fund Ltd., a fund managed by Trishield Capital Management LLC, LKCM ...
Read More


SLS's price was unchanged after the transaction was announced on 04/10/15.
Investor / Buyer
Goose Hill Capital, Ltd.
Janus Capital Group, Inc.
Janus Capital Management LLC
Lkcm Micro-Cap Partnership, L.P.
LKCM Private Discipline Master Fund, Spc
Luther King Capital Management Corporation
Milfam II, LP
Milfam LLC
Plaisance Fund LP
The Bigger Capital Fund, LP
Trishield Capital Management LLC
Trishield Special Situations Master Fund Ltd.
 
Announced 01/11/15
5.03B for NPS Pharmaceuticals, Inc.
Merger/Acquisition

Shire Pharmaceutical Holdings Ireland Limited signed an agreement to acquire NPS Pharmaceuticals, Inc. (NasdaqGS:NPSP) from shareholders for $4.9 billion in cash on January 11, 2015. The acquisition is structured as an all-cash tender offer for all of the outstanding shares of NPS Pharma at a price of $46 per share followed by a merger in which each remaining untendered share of NPS Pharma common stock would be converted into the same $46 cash per share consideration ...
Read More


SLS's price was unchanged after the transaction was announced on 01/11/15.
Investor / Buyer
Shire Pharmaceutical Holdings Ireland Limited
Creditor / Lender
Janus Capital Group, Inc.
Janus Global Life Sciences Fund
Financial Advisor
Goldman, Sachs & Co.
Leerink Partners LLC
Legal Advisor
Skadden, Arps, Slate, Meagher & Flom, L.L.P.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLS:GR €16.88 EUR -0.045

SLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AllianceBernstein Holding LP $31.31 USD -0.56
Artisan Partners Asset Management Inc $45.25 USD -0.65
Ashmore Group PLC 308.10 GBp -5.30
Azimut Holding SpA €26.05 EUR -1.26
Federated Investors Inc $33.97 USD -0.50
View Industry Companies
 

Industry Analysis

SLS

Industry Average

Valuation SLS Industry Range
Price/Earnings 22.0x
Price/Sales 3.3x
Price/Book 2.0x
Price/Cash Flow 18.5x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JANUS CAPITAL GROUP INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.